Publication | Closed Access

Effects of SU5416, a small molecule tyrosine kinase receptor inhibitor, on FLT3 expression and phosphorylation in patients with refractory acute myeloid leukemia

Hematological MalignancyMedicineMixed-phenotype Acute LeukemiaReceptor Tyrosine KinaseMalignant Blood DisorderCell BiologyOncologyRadiation OncologyCancer ResearchFlt3 ExpressionMyeloid Neoplasia